VYNE Therapeutics
VYNE
VYNE
56 hedge funds and large institutions have $68.4M invested in VYNE Therapeutics in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less capital invested
Capital invested by funds: $161M → $68.4M (-$92.3M)
Holders
56
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.71M | |
| 2 | +$1.56M | |
| 3 | +$942K | |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$710K |
| 5 |
JPMorgan Chase & Co
New York
|
+$488K |
Top Sellers
| 1 | -$4.66M | |
| 2 | -$3.25M | |
| 3 | -$1.72M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.24M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$689K |